MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$3,972,144
Free Cash flow
-$367,632
Unit: Dollar
Positive Cash Flow Breakdown
Net income
Depreciation and amortization
Stock-based compensation
Others
Negative Cash Flow Breakdown
Marketable securities settlement...
Cash dividends paid to sharehold...
Decrease in liabilities
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Net income
-232,986
-32,860
100,463
-
Net loss
-
-
-
-100,361
Gain on disposition of vehicle
0
7,000
-
-
Stock-based compensation
8,619
8,619
4,399
30,680
Depreciation and amortization
13,640
14,796
15,817
44,049
Amortization of operating lease right-of-use
0
29,388
43,359
125,850
Reinvested interests
-544
83,346
-148,220
185,746
Decrease (increase) in accounts receivable
77,977
277,116
347,839
-551,482
Decrease (increase) in prepaids and other assets
-
-
-308,312
-
Increase in other assets
-3,392
-67,619
-
27,903
Decrease in liabilities
-546,515
-148,056
79,597
-932,603
Net cash used in operating activities
-365,311
-390,139
279,666
-494,552
Acquisition of property and equipment
2,321
2,411
350
6,294
Proceeds from sale of vehicle
0
7,000
-
-
Marketable securities settlement (investment), net
-1,884,810
2,762,155
-2,063,179
603,432
Net cash provided by (used in) investing activities
-1,887,131
2,766,744
-856,665
-609,726
Repurchase of common stock
709
1,681
9,202
22,241
Cash dividends paid to shareholders
1,717,627
-
0
1,719,918
Net cash used in financing activities
-1,718,336
-1,681
-9,202
-1,742,159
Effect of exchange rate changes on cash
-1,366
9,482
7,661
36,833
Net decrease in cash and cash equivalents
-3,972,144
2,384,406
-578,540
-2,809,604
Cash and cash equivalents - beginning of period
5,763,618
3,379,212
6,767,356
-
Cash and cash equivalents - end of period
1,791,474
5,763,618
3,379,212
-
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and cash...
-$3,972,144
Net income
-$232,986
Depreciation and
amortization
$13,640
Stock-based compensation
$8,619
Increase in other assets
-$3,392
Reinvested interests
-$544
Net cash provided by
(used in) investing...
-$1,887,131
Net cash used in
financing activities
-$1,718,336
Net cash used in
operating activities
-$365,311
Effect of exchange rate
changes on cash
-$1,366
Canceled cashflow
$259,181
Marketable securities
settlement (investment),...
-$1,884,810
Acquisition of property and
equipment
$2,321
Cash dividends paid
to shareholders
$1,717,627
Repurchase of common stock
$709
Decrease in liabilities
-$546,515
Decrease (increase) in
accounts receivable
$77,977
Buy us a coffee
Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)